MBX Biosciences market cap MBX
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Nov 2, 2026
- $2.6B
- Highest close in our data
- $3.3B
- Aug 2026
MBX Biosciences is worth $2.6B at the close on Nov 2, 2026, at $54.40 a share.
That is up 128% over the last year.
Its highest close in our data was $3.3B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $2.6B | $1.3B | $3.3B | +89% |
| 2025 | $1.4B | $201.9M | $1.5B | +107% |
| 2024 | $670.7M | $588.5M | $765.6M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest MBX Biosciences' size, closest first, today.
| Company | Market cap |
|---|---|
| MBXMBX Biosciences | $2.6B |
| NRIXNurix Therapeutics | $2.8B |
| PBHPrestige Consumer Healthcare | $2.4B |
| HRMYHarmony Biosciences | $2.2B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.7B |
| ARQTArcutis Biotherapeutics | $3.9B |
| ANIPANI Pharmaceuticals | $1.6B |
| INDVIndivior Pharmaceuticals | $4.3B |
| PAHCPhibro Animal Health | $1.6B |
| PCRXPacira BioSciences | $1.5B |
| Peer median | $2.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on MBX Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.